( en | de | ru )

 

Disambiguation of "Oster, Philipp"

Author of the publication

copydeleteadd this publication to your clipboard
Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany

, , , , , , , , , and . Emerging Infectious Diseases, 16 (3): 465--472 (March 2010)PMID: 20202422.

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Kurt Oster

Franz Oster

Friedel Oster

Ulrich Oster

Thomas Oster

 

Other publications of authors with the same name

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy, , , , , , , , , and 3 other author(s). Clinical Infectious Diseases, 51 (10): 1127--1137 (November 2010)Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens, , , , , , , , , and 3 other author(s). Clinical and Vaccine Immunology : CVI, 14 (11): 1393–9 (November 2007)PMC2168176.Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life, , , , , , , , , and 2 other author(s). The Pediatric Infectious Disease Journal, (2010)Phase II Meningococcal B Vesicle Vaccine Trial in New Zealand Infants, , , , , , , , , and 2 other author(s). Archives of Disease in Childhood, (October 2008)PMID: 18838420.Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany, , , , , , , , , and . Emerging Infectious Diseases, 16 (3): 465--472 (March 2010)PMID: 20202422.MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain, , , , , and . Vaccine, 23 (17-18): 2191--6 (March 2005)PMID: 15755593.Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine, , , , , , , , , and . The Pediatric Infectious Disease Journal, 28 (5): 385--390 (May 2009)PMID: 19384263.The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic, , , , , , , , , and . The New Zealand Medical Journal, 117 (1200): U1015 (August 2004)PMID: 15475985.Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales, , , , , , , , , and 4 other author(s). J. Clin. Microbiol., 47 (11): 3577--3585 (November 2009)